Blog

Shares of Opendoor Technologies (NASDAQ: OPEN) fell last month after the real estate tech company posted disappointing results in its second-quarter earnings report. The company continues to feel

Long-term investing is the way to go if you aim to build wealth, and that means holding stocks for at least five years. But there are some companies that you'll want to hang onto for much longer

It's the Tuesday after the holiday weekend, and shares of marijuana stocks seem to have benefited greatly from the rest. Across the board, shares of cannabis companies are shooting higher. Tilray

Shares of uniQure (NASDAQ: QURE) were down more than 11% as of 1:06 p.m. on Tuesday after the gene-therapy company announced that the Food and Drug Administration (FDA) had cleared its

Shares of Brady Corporation (NYSE: BRC) were moving higher today after the diversified supplier of identification and tracking solutions posted better-than-expected results in its fiscal

Investors can be a superstitious bunch. "Sell in May and go away," for example. The stock market is supposed to have slim pickings over the summer months, and September should be one of the worst

Manchester United (NYSE: MANU) reportedly got taken off the market because its controlling shareholders failed to receive their target valuation from bidding companies. Investors are disappointed

Cleveland-Cliffs (NYSE: CLF) began the month with disappointing results, followed by an audacious bid to acquire one of its largest rivals. Investors warmed to the takeover bid, but it was the

Palantir Technologies (NYSE: PLTR) is still growing, but not as fast as investors had hoped. Investors appear to be getting impatient, sending shares of Palantir down 24.5% for the month of August

If you're trying to build a passive income stream to eventually fuel your dream retirement, Abbott Laboratories (NYSE: ABT) is a stock you probably want to know more about. This legendary dividend

Shares of Insmed (NASDAQ: INSM) were soaring 17.1% higher as of 11:27 a.m. ET on Tuesday. The big gain came after the company announced positive top-line results from its late-stage Arise clinical

Shares of Office Properties Income Trust (NASDAQ: OPI) had tumbled more than 12% by 10:30 a.m. ET on Tuesday. Weighing on the office REIT was news that it had terminated its controversial merger

The U.S. Department of Education recently launched the Savings on a Valuable Education (SAVE) Plan, the newest income-driven repayment program available to federal student loan borrowers. It is

Shares of digital real estate company Redfin (NASDAQ: RDFN) plummeted 36% in August according to data provided by S&P Global Market Intelligence. It let shareholders know that it won't meet its

Wall Street moved nicely higher last week. I thought my three stocks to avoid for that week -- Altria , Affirm , and Tilly's -- were going to lose to the market. They rose 1%, 23%, and 5%

Social Security is a lifeline for millions of retirees. The average retired worker collects roughly $1,800 per month in benefits, as of July 2023. If your savings are falling short, that money can

Shares of Zai Lab (NASDAQ: ZLAB) were up more than 10% as of 11 a.m. on Tuesday. The Chinese biotech stock rose after the company announced positive phase 3 trial data regarding Tivdak as a

In this podcast, author Jordan Ellenberg shows us that the power of mathematical thinking can lead you to smarter, happier, and richer outcomes.

To catch full episodes of all The Motley Fool's free

Shares of America's Car-Mart (NASDAQ: CRMT) had collapsed by 12.2% as of 10:58 a.m. ET Tuesday after the used car dealer reported a big earnings miss and a change in management before the trading

The e-commerce market hasn't been the most reliable place to invest in recent years. The pandemic sent stocks skyrocketing as homebound consumers took to buying essentials online. Then, an economic

The stock market has been through a volatile few weeks. Since the end of July, the Nasdaq Composite index, which is chock-full of growth stocks, fell more than 7% at its low point, then swiftly

The momentum in the Nasdaq may have stalled in August, but there's no question the tech-heavy index is having a banner year, making a robust recovery from a dismal 2022. Year to date, the Nasdaq is

In this video, I will talk about Ulta Beauty (NASDAQ: ULTA), the current state of the company, the highlights from its recent earnings report, and why I believe long-term investors should take

In mid-August, Novartis (NYSE: NVS) shared positive results from the phase 3 clinical trial of its biosimilar to Regeneron (NASDAQ: REGN) and Bayer AG's (OTC: BAYR.Y) Eylea. The Swiss drugmaker's

Fool.com contributor Parkev Tatevosian discusses the progress Nio (NYSE: NIO) has made in three major areas of its business.

*Stock prices used were the afternoon prices of Sept. 2, 2023. The video